Closing Strong: Fractyl Health Inc (GUTS) Ends at $2.0 on Monday

Kevin Freeman

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 2.35 million shares were traded. GUTS stock price reached its highest trading level at $2.03 during the session, while it also had its lowest trading level at $1.95.

Ratios:

Our goal is to gain a better understanding of GUTS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.27 and its Current Ratio is at 4.27.

Upgrades & Downgrades

In the most recent recommendation for this company, H.C. Wainwright on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $9.

On August 28, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $3.60.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’25 when Rajagopalan Harith bought 10,416 shares for $1.92 per share. The transaction valued at 19,999 led to the insider holds 501,745 shares of the business.

Royan Ajay bought 17,901 shares of GUTS for $22,980 on Mar 14 ’25. The Director now owns 17,901 shares after completing the transaction at $1.28 per share. On Mar 14 ’25, another insider, Barnes Kelly Ann, who serves as the Director of the company, bought 31,000 shares for $1.30 each. As a result, the insider paid 40,210 and bolstered with 31,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 306744096 and an Enterprise Value of 258615872. Its current Enterprise Value per Revenue stands at 86205.3 whereas that against EBITDA is -2.648.

Stock Price History:

The Beta on a monthly basis for GUTS is 1.61, which has changed by 0.11731839 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.03, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 12.70%, while the 200-Day Moving Average is calculated to be 31.41%.

Shares Statistics:

The stock has traded on average 2.83M shares per day over the past 3-months and 2755990 shares per day over the last 10 days, according to various share statistics. A total of 132.22M shares are outstanding, with a floating share count of 113.53M. Insiders hold about 17.16% of the company’s shares, while institutions hold 57.63% stake in the company. Shares short for GUTS as of 1767139200 were 11893654 with a Short Ratio of 4.20, compared to 1764288000 on 9071777. Therefore, it implies a Short% of Shares Outstanding of 11893654 and a Short% of Float of 8.870000000000001.

Earnings Estimates

. The current assessment of Fractyl Health Inc (GUTS) involves the perspectives of 5.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.13 and low estimates of -$0.17.

Analysts are recommending an EPS of between -$1.2 and -$1.93 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is -$0.69, with 5.0 analysts recommending between -$0.54 and -$0.88.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.